Home > Insider Trading > Filing (0001225208-14-024749)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
310158	Merck & Co. Inc.	MRK	Pharmaceutical Preparations (2834)	221918501

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1181175	C Kenneth Frazier	2000 Galloping Hill Road Kenilworth NJ 07033	Chairman, President & Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2014-12-10	9,333	$35.09	353,753	No	4	M	Direct
Common Stock	Acquisiton	2014-12-10	3,541	$31.84	357,294	No	4	M	Direct
Common Stock	Disposition	2014-12-10	9,846	$60.00	347,448	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2014-12-10	3,541	$0.00	3,541	$31.84
Common Stock	Stock Option (right to buy)	Disposition	2014-12-10	9,333	$0.00	9,333	$35.09

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
10,623	2006-02-25	2015-02-24	No	4	M	Direct
27,999	2007-03-03	2016-03-02	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock - 401(K) Plan	3,519	Indirect	By 401(k)

Footnotes

The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.
Holdings include shares acquired in dividend reinvestment transactions.
Includes shares acquired and dividends earned through October 7, 2014, in the Merck U.S. Savings Plan, a 401(k) plan.
The option became exercisable in equal installments on 2/25/2006, 2/25/2007 and 2/25/2008.
The option became exercisable in equal installments on 3/3/2007, 3/3/2008 and 3/3/2009.